Pharmacoeconomic Fellowships Vittorio MaioTammy K. GirtsDavid B. Nash Leading Article 23 September 2012 Pages: 795 - 802
The Impact of Health Economics on Healthcare Delivery Ruth McDonaldAlan HaycoxTom Walley Commentary 23 September 2012 Pages: 803 - 809
A Review of the Direct Costs of Rheumatoid Arthritis Deborah P. Lubeck Review Article 23 September 2012 Pages: 811 - 818
The Cost Effectiveness of Stratified Care in the Management of Migraine Paul WilliamsAndrew J. DowsonJames Sawyer Original Research Article 23 September 2012 Pages: 819 - 829
Cost Effectiveness in Canada of a Multidrug Prepackaged Regimen (Hp-PAC®) for Helicobacter pylori Eradication Karen AgroGordon BlackhouseBernie J. O’Brien Original Research Article 23 September 2012 Pages: 831 - 843
Incremental Cost Analysis of Ambulatory Clinic and Home-Based Intravenous Therapy for Patients with Multiple Myeloma Peter C. CoyteMark J. DobrowLarry Broadfield Original Research Article 23 September 2012 Pages: 845 - 854
Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer Sabrina TrippoliMonica VaianiQuality-of-life Study Group of the Master 2 Project in Pharmacoeconomics Original Research Article 23 September 2012 Pages: 855 - 863
Cost-Efficacy Analysis of Fluticasone Propionate versus Zafirlukast in Patients with Persistent Asthma Rogelio MenendezRichard H. StanfordKathleen Rickard Original Research Article 23 September 2012 Pages: 865 - 874
Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson’s Disease in Japan Takuro ShimboKenji HiraTsuguya Fukui Original Research Article 23 September 2012 Pages: 875 - 886